Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the week. This latest feature of MassDevice.com’s coverage highlights our seven biggest and most influential stories from the week’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else this weekend, make sure you’re still in the know with MassDevice +7.
Johnson & Johnson subsidiary Animus Corp. warns that certain of its Animas insulin pumps will become defunct at the stroke of midnight on December 31, 2015.
Medical device tax opponents Sens. Amy Klobuchar (D-Minn.) and Al Franken (D-Minn.) discuss ways in which repeal efforts failed and look for new in-roads to bring back the fight.
Whistleblower Meng-Lin Liu accuses Siemens China of engaging in an illegal kickbacks scheme and of firing him when he brought evidence to the company’s regional CFO.
Group purchaser Novation is "taking a firm stance" against medical device makers billing healthcare providers to cover the cost of a 2.3% sales tax.
Nearly 40% of Johnson & Johnson subsidiary DePuy Orthopaedics’ recalled ASR metal-on-metal hip implants may fail within 5 years, according to an internal analysis uncovered during a patient injury lawsuit.
Sen. Chuck Grassley (R-Iowa) calls for the Obama Administration to put the final touches on the Physician Payments Sunshine Act, a bill that Grassley co-authored and introduced in 2007.
Federal officials decide not to appeal a recent court decision that protected a salesman’s off-label marketing activities as free speech.